PLCD1
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-1
Also known as: PLCD1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P51178
- Gene
- PLCD1
- Ensembl
- ENSG00000187091
- Chromosome
- 3
- Canonical length
- 756 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins
- Subcellular location
- Microtubules
OverviewNCBI Gene
This gene encodes a member of the phospholipase C family. Phospholipase C isozymes play critical roles in intracellular signal transduction by catalyzing the hydrolysis of phosphatidylinositol 4,5-bisphosphate (PIP2) into the second messengers diacylglycerol (DAG) and inositol triphosphate (IP3). The encoded protein functions as a tumor suppressor in several types of cancer, and mutations in this gene are a cause of hereditary leukonychia. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Dec 2011]
Canonical amino-acid sequenceUniProt
756 residues, UniProt reviewed canonical sequence.
>P51178|PLCD1
1 MDSGRDFLTL HGLQDDEDLQ ALLKGSQLLK VKSSSWRRER FYKLQEDCKT IWQESRKVMR
61 TPESQLFSIE DIQEVRMGHR TEGLEKFARD VPEDRCFSIV FKDQRNTLDL IAPSPADAQH
121 WVLGLHKIIH HSGSMDQRQK LQHWIHSCLR KADKNKDNKM SFKELQNFLK ELNIQVDDSY
181 ARKIFRECDH SQTDSLEDEE IEAFYKMLTQ RVEIDRTFAE AAGSGETLSV DQLVTFLQHQ
241 QREEAAGPAL ALSLIERYEP SETAKAQRQM TKDGFLMYLL SADGSAFSLA HRRVYQDMGQ
301 PLSHYLVSSS HNTYLLEDQL AGPSSTEAYI RALCKGCRCL ELDCWDGPNQ EPIIYHGYTF
361 TSKILFCDVL RAIRDYAFKA SPYPVILSLE NHCTLEQQRV MARHLHAILG PMLLNRPLDG
421 VTNSLPSPEQ LKGKILLKGK KLGGLLPPGG EGGPEATVVS DEDEAAEMED EAVRSRVQHK
481 PKEDKLRLAQ ELSDMVIYCK SVHFGGFSSP GTPGQAFYEM ASFSENRALR LLQESGNGFV
541 RHNVGHLSRI YPAGWRTDSS NYSPVEMWNG GCQIVALNFQ TPGPEMDVYQ GRFQDNGACG
601 YVLKPAFLRD PNGTFNPRAL AQGPWWARKR LNIRVISGQQ LPKVNKNKNS IVDPKVTVEI
661 HGVSRDVASR QTAVITNNGF NPWWDTEFAF EVVVPDLALI RFLVEDYDAS SKNDFIGQST
721 IPLNSLKQGY RHVHLMSKNG DQHPSATLFV KISLQDLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PLCD1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.23
- Highest tissue expression
- 34 nTPM
Expression across tissuesHPA
Tissue
- testis: 34 nTPM
- blood vessel: 29 nTPM
- esophagus: 26 nTPM
- vagina: 19 nTPM
- skin: 19 nTPM
- cervix: 18 nTPM
Single-cell type
- esophageal apical cells: 95 nCPM
- sertoli cells: 89 nCPM
- colonocytes: 75 nCPM
- esophageal suprabasal cells: 67 nCPM
- goblet cells: 55 nCPM
- urothelial cells: 53 nCPM
Immune cell
- memory CD4 T-cell: 17 nTPM
- T-reg: 17 nTPM
- MAIT T-cell: 15 nTPM
- basophil: 15 nTPM
- gdT-cell: 13 nTPM
- memory CD8 T-cell: 13 nTPM
Brain region
- white matter: 36 nTPM
- medulla oblongata: 34 nTPM
- spinal cord: 32 nTPM
- hypothalamus: 31 nTPM
- midbrain: 30 nTPM
- thalamus: 27 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about PLCD1.
Disease | AllUniProt
Conditions PLCD1 is implicated in, by any mechanism.
- Nail disorder, non-syndromic congenital, 3 (NDNC3) MIM:151600
Disease | GeneticClinVar
10 pathogenic / likely-pathogenic of 249 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Nonsyndromic congenital nail disorder 3
- PLCD1-related disorder
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.1
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.24
- DepMap mean gene effect
- 0.03
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- lipid catabolic process
- phosphatidylinositol metabolic process
- phospholipase C/protein kinase C signal transduction
- phospholipid metabolic process
Molecular functions
- calcium ion binding
- GTPase activating protein binding
- phosphatidic acid binding
- phosphatidylinositol phospholipase C activity
- phosphatidylinositol-4,5-bisphosphate binding
- phosphatidylinositol-4,5-bisphosphate phospholipase C activity
- phosphatidylserine binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- C2 domain
- Phosphatidylinositol-specific phospholipase C, X domain
- Phosphoinositide phospholipase C family
- Phospholipase C, phosphatidylinositol-specific, Y domain
- Pleckstrin homology domain
- EF-hand domain
- EF-hand domain pair
- PH-like domain superfamily
- Phosphoinositide-specific phospholipase C, EF-hand-like domain
- PLC-like phosphodiesterase, TIM beta/alpha-barrel domain superfamily
- EF-Hand 1, calcium-binding site
- C2 domain superfamily
- C2 domain
- Phosphatidylinositol-specific phospholipase C, Y domain
- Phosphatidylinositol-specific phospholipase C, X domain
- Phosphoinositide-specific phospholipase C, efhand-like
- Pleckstrin homology domain
- 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-1, catalytic domain
- 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-1, EF-hand domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PLCD1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PLCD1 as an antibody target. Whether an autoantibody or antibody against PLCD1 could matter depends on whether native PLCD1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PLCD1 is annotated at the cell surface, where native PLCD1 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label PLCD1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...